We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Effects of Chemoradiation Therapy on Hearing in Patients with Malignancy of Head and Neck

    Purpose: To study effects of chemoradiation therapy on hearing in patients with malignancy of head and neck. Methods and materials: Patients...

    Shobit Yadav, Digant Patni, V. R. Munjal in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 20 April 2023
  2. Total Neoadjuvant Therapy in Rectal Cancer: Multi-center Comparison of Induction Chemotherapy and Long-Course Chemoradiation Versus Short-Course Radiation and Consolidative Chemotherapy

    Background

    Total neoadjuvant therapy for locally advanced rectal cancer may include induction chemotherapy and chemoradiation or short-course...

    Amber M. Moyer, Jon D. Vogel, ... Brandon C. Chapman in Journal of Gastrointestinal Surgery
    Article 09 February 2023
  3. Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?

    Background

    Neoadjuvant chemoradiation therapy (NCRT, 5-fluorouracil and radiation) followed by resection and adjuvant chemotherapy (AC) is one of the...

    Jessica M. Keilson, Adriana C. Gamboa, ... Glen C. Balch in Annals of Surgical Oncology
    Article 21 October 2022
  4. Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics

    Purpose

    To assess the role of pretreatment multiparametric (mp)MRI-based radiomic features in predicting pathologic complete response (pCR) of locally...

    Maria El Homsi, Octavia Bane, ... Bachir Taouli in Abdominal Radiology
    Article 27 December 2023
  5. Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database

    Background

    There is a paucity of evidence supporting the use of adjuvant radiation therapy in resected biliary cancer. Supporting evidence for use...

    Dana A. Dominguez, Paul Wong, ... Laleh G. Melstrom in Annals of Surgical Oncology
    Article Open access 05 March 2024
  6. Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option?

    Background

    Neoadjuvant chemoradiation therapy (nCRT) is recommended when lymph node metastasis is evident or strongly suspected on preoperative...

    Young Ho Yang, Byung Jo Park, ... Dae Joon Kim in Annals of Surgical Oncology
    Article 28 December 2023
  7. MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer

    Purpose

    To investigative the performance of MRI-radiomics analysis derived from T2WI and apparent diffusion coefficients (ADC) images before and after...

    Zhu Fang, Hong Pu, ... Hang Li in Abdominal Radiology
    Article 21 April 2023
  8. Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report

    Background

    Longitudinal extensive transverse myelitis is a rare and potentially life-threatening complication of chemoradiation. Certain chemotherapy...

    Travis Moodie, Ola Alshaqi, Abdul Alchaki in BMC Neurology
    Article Open access 19 March 2022
  9. Influence of chemoradiation on the immune microenvironment of cervical cancer patients

    Purpose

    Cervical cancer remains a leading cause of cancer death in women. While immunotherapy has shown great success in combating cancer, the value...

    J. M. Herter, M. Kiljan, ... S. Marnitz in Strahlentherapie und Onkologie
    Article Open access 17 October 2022
  10. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series

    Background

    Palmar-plantar erythrodysesthesia (PPE) is a slowly develo** cutaneous reaction commonly experienced by patients treated with...

    Angela Adames, Diana Roth O’Brien, ... Paul B. Romesser in International Journal of Colorectal Disease
    Article Open access 23 May 2024
  11. Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors

    Purpose

    Diffuse gliomas are managed with radiation and temozolomide; however, this therapy often results in hematologic toxicities. Patients...

    Lisa M. Arnold, Yoji Hoshina, ... Joe Mendez in Journal of Neuro-Oncology
    Article 16 February 2024
  12. Primary squamous cell carcinoma of the thyroid treated with concurrent chemoradiation and palliative immunotherapy: a case report

    Background

    Primary squamous cell carcinoma of the thyroid is a very rare malignancy with aggressive growth and poor prognosis. There is currently no...

    Meng-Lun Hsieh, Brian M. Besch, ... Christina Henson in Journal of Medical Case Reports
    Article Open access 05 October 2022
  13. Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma

    Purpose

    To report the long-term outcomes in adult patients with grade 2 IDH-mutant astrocytoma treated with temozolomide (TMZ)-based chemoradiation....

    Giuseppe Minniti, Sergio Paolini, ... Vincenzo Esposito in Journal of Neuro-Oncology
    Article Open access 04 September 2023
  14. Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma

    Purpose

    Low-grade glioma (LGG) exhibits longer median survival than high-grade brain tumors, and thus impact of our therapies on patient quality of...

    Deborah Y. Park, Martin C. Tom, ... Erin S. Murphy in Journal of Neuro-Oncology
    Article 22 January 2022
  15. Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas

    Purpose

    We sought to evaluate the effects of concurrent temozolomide-based chemoradiation therapy on neurocognitive function in patients with...

    Deborah Y. Park, Martin C. Tom, ... Erin S. Murphy in Journal of Neuro-Oncology
    Article 29 April 2022
  16. Estimating Risk of Locoregional Failure and Overall Survival in Anal Cancer Following Chemoradiation: A Machine Learning Approach

    Background

    Optimal treatment of anal squamous cell carcinoma (ASCC) is definitive chemoradiation. Patients with persistent or recurrent disease...

    Kevin A. Chen, Paolo Goffredo, ... Muneera R. Kapadia in Journal of Gastrointestinal Surgery
    Article 05 July 2023
  17. Longer Time Interval from Neoadjuvant Chemoradiation to Surgery is Associated with Poor Survival for Patients Without Clinical Complete Response in Oesophageal Cancer

    Background

    The optimal interval between neoadjuvant therapy and oesophagectomy for oesophageal cancer remains controversial.

    Methods

    Patients with...

    **n **ao, Chao Cheng, ... Yong Yuan in Annals of Surgical Oncology
    Article 02 November 2022
  18. Psychosocial consequences of head and neck cancer symptom burden after chemoradiation: a mixed-method study

    Purpose

    Patients with head and neck cancer (HNC) experience significant symptom burden from combination chemotherapy and radiation (chemoradiation)...

    Carley Geiss, Aasha I. Hoogland, ... Laura B. Oswald in Supportive Care in Cancer
    Article 27 March 2024
  19. Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma

    Background

    Performing selective esophagectomy for locally advanced squamous cell carcinoma may spare patients morbidity, but delayed surgery may infer...

    Lye-Yeng Wong, Douglas Z. Liou, ... Mark F. Berry in Annals of Surgical Oncology
    Article 26 December 2022
Did you find what you were looking for? Share feedback.